UBS Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,383,825
| Closed | -$2.12M | – | 9958 |
|
|
2022
Q4 | $2.12M | Buy |
2,383,825
+2,149,187
| +916% | +$1.91M | ﹤0.01% | 2524 |
|
|
2022
Q3 | $369K | Sell |
234,638
-900,431
| -79% | -$1.42M | ﹤0.01% | 3615 |
|
|
2022
Q2 | $2.28M | Sell |
1,135,069
-1,345,692
| -54% | -$2.7M | ﹤0.01% | 2310 |
|
|
2022
Q1 | $5.78M | Buy |
2,480,761
+1,631,874
| +192% | +$3.8M | ﹤0.01% | 1818 |
|
|
2021
Q4 | $3.95M | Buy |
848,887
+369,268
| +77% | +$1.72M | ﹤0.01% | 2309 |
|
|
2021
Q3 | $3.66M | Buy |
479,619
+324,010
| +208% | +$2.47M | ﹤0.01% | 2273 |
|
|
2021
Q2 | $1.51M | Sell |
155,609
-139,713
| -47% | -$1.35M | ﹤0.01% | 2948 |
|
|
2021
Q1 | $2.44M | Buy |
295,322
+185,857
| +170% | +$1.54M | ﹤0.01% | 2589 |
|
|
2020
Q4 | $747K | Buy |
109,465
+6,347
| +6% | +$43.3K | ﹤0.01% | 3368 |
|
|
2020
Q3 | $1.15M | Buy |
103,118
+33,171
| +47% | +$370K | ﹤0.01% | 2829 |
|
|
2020
Q2 | $439K | Sell |
69,947
-28,092
| -29% | -$176K | ﹤0.01% | 3497 |
|
|
2020
Q1 | $180K | Sell |
98,039
-67,624
| -41% | -$124K | ﹤0.01% | 3972 |
|
|
2019
Q4 | $560K | Buy |
165,663
+64,030
| +63% | +$216K | ﹤0.01% | 3806 |
|
|
2019
Q3 | $218K | Buy |
101,633
+75,494
| +289% | +$162K | ﹤0.01% | 4295 |
|
|
2019
Q2 | $69K | Sell |
26,139
-444
| -2% | -$1.17K | ﹤0.01% | 4808 |
|
|
2019
Q1 | $126K | Sell |
26,583
-668,643
| -96% | -$3.17M | ﹤0.01% | 4142 |
|
|
2018
Q4 | $1.67M | Buy |
695,226
+532,674
| +328% | +$1.28M | ﹤0.01% | 2583 |
|
|
2018
Q3 | $715K | Buy |
162,552
+118,669
| +270% | +$522K | ﹤0.01% | 3414 |
|
|
2018
Q2 | $316K | Sell |
43,883
-398,175
| -90% | -$2.87M | ﹤0.01% | 3839 |
|
|
2018
Q1 | $2.28M | Buy |
442,058
+418,848
| +1,805% | +$2.16M | ﹤0.01% | 2450 |
|
|
2017
Q4 | $88K | Buy |
23,210
+21,710
| +1,447% | +$82.3K | ﹤0.01% | 4517 |
|
|
2017
Q3 | $3K | Sell |
1,500
-2,043
| -58% | -$4.09K | ﹤0.01% | 6492 |
|
|
2017
Q2 | $7K | Buy |
3,543
+1,240
| +54% | +$2.45K | ﹤0.01% | 6052 |
|
|
2017
Q1 | $9K | Sell |
2,303
-157,967
| -99% | -$617K | ﹤0.01% | 5774 |
|
|
2016
Q4 | $786K | Buy |
160,270
+32,938
| +26% | +$162K | ﹤0.01% | 2992 |
|
|
2016
Q3 | $986K | Buy |
127,332
+33,815
| +36% | +$262K | ﹤0.01% | 2752 |
|
|
2016
Q2 | $524K | Buy |
93,517
+87,017
| +1,339% | +$488K | ﹤0.01% | 3115 |
|
|
2016
Q1 | $35K | Buy |
6,500
+1,018
| +19% | +$5.48K | ﹤0.01% | 4963 |
|
|
2015
Q4 | $48K | Sell |
5,482
-469
| -8% | -$4.11K | ﹤0.01% | 4785 |
|
|
2015
Q3 | $50K | Buy |
5,951
+5,200
| +692% | +$43.7K | ﹤0.01% | 4715 |
|
|
2015
Q2 | $13K | Sell |
751
-1,860
| -71% | -$32.2K | ﹤0.01% | 5826 |
|
|
2015
Q1 | $30K | Buy |
2,611
+2,060
| +374% | +$23.7K | ﹤0.01% | 5052 |
|
|
2014
Q4 | $6K | Buy |
+551
| New | +$6K | ﹤0.01% | 6280 |
|